KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $12.37 $15.59 Friday, 26th Apr 2024 URGN stock ended at $14.15. This is 2.39% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 4.60% from a day low at $13.69 to a day high of $14.32.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Apr 26, 2024 $13.97 $14.32 $13.69 $14.15 134 451
Apr 25, 2024 $14.05 $14.50 $13.77 $13.82 176 631
Apr 24, 2024 $14.66 $14.76 $14.19 $14.21 91 852
Apr 23, 2024 $14.40 $14.85 $14.11 $14.53 216 640
Apr 22, 2024 $13.80 $14.51 $13.58 $14.37 272 728
Apr 19, 2024 $14.06 $14.28 $13.17 $13.73 380 995
Apr 18, 2024 $14.36 $14.54 $13.96 $14.26 308 514
Apr 17, 2024 $14.61 $14.66 $14.02 $14.24 169 601
Apr 16, 2024 $14.86 $15.05 $14.16 $14.49 401 866
Apr 15, 2024 $15.32 $15.43 $14.21 $15.10 657 208
Apr 12, 2024 $13.09 $15.21 $13.00 $15.10 1 215 467
Apr 11, 2024 $13.14 $13.25 $12.37 $13.25 252 393
Apr 10, 2024 $13.20 $13.20 $12.58 $12.95 307 233
Apr 09, 2024 $13.32 $13.91 $13.21 $13.37 200 976
Apr 08, 2024 $13.64 $13.64 $13.18 $13.21 122 922
Apr 05, 2024 $13.54 $13.97 $13.21 $13.60 127 582
Apr 04, 2024 $13.77 $14.30 $13.50 $13.64 211 015
Apr 03, 2024 $14.00 $14.26 $13.47 $13.66 170 760
Apr 02, 2024 $14.28 $14.52 $13.00 $14.09 188 420
Apr 01, 2024 $14.75 $14.75 $14.16 $14.20 179 151
Mar 28, 2024 $14.92 $15.25 $14.56 $15.00 168 410
Mar 27, 2024 $15.59 $15.59 $14.46 $14.96 248 861
Mar 26, 2024 $16.80 $16.85 $14.99 $15.17 385 908
Mar 25, 2024 $16.19 $18.22 $16.00 $16.66 889 314
Mar 22, 2024 $14.89 $16.17 $14.73 $15.76 2 249 620
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT